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ABSTRACT
Objectives: The aim of our study was to evaluate the association of vitamin D deficiency (VDD) during pregnancy with 
thymus size in full-term fetuses.
Material and methods: In this prospective study, we evaluated mid-pregnancy serum 25-hydroxyvitamin D3 (25(OH)D3) 
concentrations. The fetal thymus size was measured by ultrasound in the third trimester. Neonatal 25(OH)D3 levels were 
evaluated by umbilical cord blood sampling. Correlation of maternal and neonatal vitamin D levels and association between 
thymus size and both, maternal and neonatal vitamin D concentrations were investigated. 
Results: Serum 25(OH) D3 concentrations were within the normal range in 48 (29.8%) mothers and 10 (13.1%) new-
borns. A strong correlation between mid-pregnancy maternal and neonatal 25(OH)D3 concentration (r = 0.8, p < 0.001) 
was found. A significant linear correlation was observed between both, maternal and neonatal 25(OH)D3 concentrations 
and thymus perimeter length (r = 0.45, p = 0.04 and r = 0.43, p < 0.01, respectively). Both, maternal and fetal VDDs were 
associated with decreased thymus perimeter (p = 0.04, p = 0.03).
Conclusions: Vitamin D deficiency during pregnancy may be associated with smaller fetal thymus. Our data suggest that 
VDD in pregnancy may lead to systemic inflammatory response in the fetus.
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INTRODUCTION
Recent studies have shown that, beyond its role in bone 
metabolism, calcium and phosphorus homeostasis, vitamin D 
exerts profound effects in the immune system [1, 2]. Studies in 
both, animal models and in humans have demonstrated that 
vitamin D deficiency (VDD) contributes to the exacerbation of 
both, infectious and autoimmune diseases through dysfunc-
tional regulatory T cells [3, 4]. The function of regulatory T cells 
in inflammatory diseases of the neonatal and early childhood 
period (e.g. allergy to cow’s milk, atopic eczema, asthma, and 
wheezing) is closely related to VDD during pregnancy [5, 6]. 
Umbilical cord T-cell receptors, which are direct indicators of 
T-Lymphocyte synthesis and, consequently, thymic output, 
are negatively correlated with vitamin D levels [7]. As a result, 
a hypothesis has been advanced that the season in which 
a baby was born may influence autoimmune and atopic dis-
order risk in later life. Regardless, the underlying mechanism 
of the association between vitamin D and the development 
of the fetal immune system remains unclear. 
The thymus is the primary site of T cell differentiation 
in early life. This maturation process is specific to the fetal 
period, but antigenic and environmental changes during 
that time may affect the programming of the immune sys-
tem [8]. Moreover, the thymus has been shown to actively 
respond to systemic fetal inflammation during the intrau-
terine period [9, 10]. This non-specific anti-inflammatory 
response may be triggered by endogenous corticoster-
oids, systemic inflammatory mediators, and deficiency in 
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the intake of proteins, minerals or vitamins [11–13]. Fetal 
thymus size may be a good marker of fetal systemic inflam-
matory response [14, 15]. Recent studies have revealed fetal 
thymus size to be positively correlated with the umbilical 
cord C-reactive protein (CRP) levels in cases with preterm 
premature membrane rupture (PPROM) and a strong pre-
dictor of neonatal sepsis. Additionally, it is suggested that 
thymus size is smaller in fetuses of preeclamptic mothers as 
compared to healthy controls, independently of coexisting 
SGA status and antenatal steroid use [16–18]. 
In our study, we evaluated the correlation between 
both, mid-pregnancy maternal and neonatal 25-hydroxy-
vitamin D3 (25(OH)D3) concentration and fetal thymus size. 
We hypothesized that VDD during pregnancy might alter 
the immune system by affecting thymic development. 
Furthermore, restricted fetal thymus size is an accepted 
indicator of the systemic inflammatory response and VDD 
during pregnancy may cause fetal systemic inflammatory 
response.
MATERIAL AND METHODS
Study design
The study design was reviewed and approved by the 
Local Ethics Committee. All study subjects provided written 
consent according to the procedures recommended by the 
1975 Declaration of Helsinki Declaration (revised in Tokyo 
2004). All study data were collected from September 2013 to 
March 2014. During the study period, there were 142 vagi-
nal and 204 cesarean section deliveries in our clinic. After 
obtaining informed consent, healthy volunteers between 
24 and 28 weeks of pregnancy attending routine antenatal 
examination were recruited for the study. Exclusion crite-
ria were: intrauterine growth retardation, fetal anomaly, 
multi-fetal pregnancy, maternal hypertension, chronic liver 
or renal disease, gastrointestinal disease, rheumatic disease, 
current tobacco use, or any ongoing chronic medical thera-
pies. The daily dose of 400 IU vitamin D supplements was 
recommended to all pregnant women.
We hypothesized that if vitamin D deficiency during 
pregnancy leads to a low-level chronic inflammatory re-
sponse at fetal thymus unlike pre-eclampsia or chorioamnio-
nitis, the evaluation of a relationship between vitamin D level 
in mid-pregnancy and fetal thymus size in late pregnancy 
may be a more appropriate approach. Therefore, maternal 
blood samples for the measurement of 25(OH)D3 level were 
collected between 20–28 weeks of gestation and fetal thy-
mus measurement was performed at 37–40 weeks of gesta-
tion. The study population included 204 pregnant women. 
Forty-two pregnant women were excluded in accordance to 
the exclusion criteria in the first step. A total of 162 pregnant 
women who met the inclusion criteria were enrolled in the 
study. Pregnant women were followed up until delivery. Ul-
trasound measurement of fetal thymus size was performed 
during 37–40 weeks of gestation. The ultrasound image 
quality was judged to be poor in 44 patients who, together 
with 20 patients who were diagnosed with pre-eclampsia, 
gestational diabetes, PPROM or preterm labor, as well as 
20 pregnant women who were missing at monitoring, were 
excluded from the study in the second step. Finally, cord 
blood samples were taken from 76 neonates at delivery. 
Figure 1 represents a flow chart of the study design.
Measurement of fetal thymus 
A high resolution ultrasound device (Siemens; Acuson 
Anteres, Mountain View, CA 94043, USA) was used to per-
form all ultrasound measurements by two experienced 
radiologists with extensive qualifications in obstetric ul-
trasonography. 
The fetal thymus was imaged in transverse at the point 
of the upper mediastinum adjacent to the three large car-
diac vessels. The homogeneous structure within the ante-
rior mediastinum was identified as the thymus (Figure 2A). 
Maximum transverse thymic diameter was defined as the 
diameter at the point perpendicular to the line connecting 
the spine and sternum and the complete perimeter was 
measured in the same plane (Figure 2B). Poor image quality 
was considered an exclusion criterion. An image was identi-
fied as poor quality under the following conditions: inability 
to identify the sternum and the spine, presence of multiple 
ribs on either side of the thorax, indicating obliquity, inability 
to identify the transverse thymic border [18].
A pair of observers, blinded to patient data as well as 
the assessment of the other observer, examined 40 out of 
150 patients enrolled in the study to assess inter-observer 
reliability. Ultrasonic thymic perimeter and thymus/thorax 
diameter intra-observer reproducibility were 1.5–2.0% and 
1.8–3.2%, respectively.
Sample collection
Serum 25(OH)D3 is a marker of both, dietary vitamin D 
intake and cutaneous synthesis of vitamin D. The normal 
range of serum 25(OH)D3 in pregnant women has not 
been determined. Based on previous studies in non-preg-
nant women, VDD was defined as 25(OH)D3 ≤ 20 ng/mL 
(50 nmol/L). Mild vitamin D deficiency was defined as serum 
25(OH) D3 concentration of 10–20 ng/mL (25–50 nmol/L), 
whereas severe vitamin D deficiency was defined as serum 
25(OH)D3 concentration of ≤ 10 ng/mL (≤ 25 nmol/L).
Maternal blood samples were collected within 20–28 
weeks of gestation and neonatal blood was collected from 
the umbilical cord after delivery and clamping. Serum was 
separated from whole blood and stored at –30ºC until an-
alyzed. Isotope dilution liquid chromatography-tandem 
mass spectrometry (LC-MS/MS) was used to measure 
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25(OH) D3 concentration. The NIST SRM 972 (Chromsystems, 
DE) calibrators were used.
BMI [weight (kg)/height (m)2] was calculated by measur-
ing the height and the body weight at maternal vitamin  D 
sampling.
Statistical analysis
SPSS (15.0) for Windows (SPSS Inc., Chicago, IL, USA) was 
used for all statistical analyses. The ANOVA test was used to 
test for differences within the groups. Factors associated with 
VDD were evaluated using multiple linear regression. The 
Pearson’s correlation test was used to evaluate the relation-
ship between thymus perimeter and diameter, as well as ma-
ternal and neonatal 25(OH)D3 concentrations. Differences in 
thymus perimeter according to cord blood 25(OH)D3 concen-
tration were evaluated using ANOVA. The p-value of 0.05 was 
established as the threshold of statistical significance.
RESULTS
Mean age, BMI, and week of pregnancy were 
29.5 ± 4.3 years, 28.8 ± 2.6, and 38.7 ± 0.9 weeks, respec-
tively. Average maternal serum 25(OH)D3 concentration 
was 15.06 ± 6.9 ng/mL and mean umbilical cord serum 
25(OH)D3 concentration was 12.32 ± 4.8 ng/mL. A total 
of 48 mothers (29.8%) and 10 newborns (13.1%) had se-
rum 25(OH)D3 concentrations within the normal range. 
Fifty-seven mothers (35.1%) and 26 (34.2%) newborns had 
mild vitamin D deficiency, whereas 57 (35.1%) mothers and 
40 (52.6%) newborns had severe vitamin D deficiency. The 
basic characteristics of the study group and the 25(OH) D3 re-
sults are summarized in Table 1.
A strong statistical correlation between umbilical cord 
serum 25(OH)D3 concentration and maternal serum 25(OH)
D3 concentration (r = 0.8, p < 0.001) was found (Figure 3).
Measurements of the fetal thymus perimeter were sig-
nificantly correlated with the thymic-thoracic ratio (r = 0.4, 
p < 0.01).
A B
Figure 2. Sonogram of the thymus at the level of the 3-vessel view 
within the fetal thorax. A. Thymic-thoracic ratio. Tymus diameter was 
measured as its greatest width perpendicular to a line connecting the 
spine and sternum. B. Thymic perimeter
42 pregnant women were exluded according to
exclusion criteria in the rst step
20 patients who were diagnosed pre-eclampsia,
gestational diabetes, preterm labour or PPROM
and
44 patients who had low quality fetal thymus
measurement were excluded in the second step
20 missing data
2 missing data
Cord blood samples
were taken from
neonates at delivery
n = 76
Fatal thymus size were
measured at 37–40.
gestational week
n = 78
Source population
n = 204
Eligable participants
screended for vitamin D
in mid-pregnancy
n = 162
Figure 1. Flow chart of the study design. PPROM — preterm premature membrane rupture
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A statistically significant linear correlation between 
both, maternal serum and umbilical cord 25(OH)D3 con-
centration and thymus perimeter was observed (r = 0.45, 
p = 0.04 and r = 0.43, p < 0.01, respectively) (Figure 4).
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Figure 3. The relationship between serum 25(OH)D3 concentrations 
of mothers and in umbilical cord serum at delivery (Pearson 
Correlation coefficient = 0.8, p < 0.01)
Figure 4. The relationship between thymus perimeter and 25(OH)D3 
concentrations in umbilical cord serum at delivery (Pearson 
Correlation coefficient = 0.4, p < 0.01) 
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Table 1. General characteristics and vitamin D status of the mothers and newborns in the study
Mean (± SD)
Age (years)  29.5 ± 4.3
Mean gestational week (maternal vitamin D sampling) 25 ± 0.5
Mean gestational week (thymus measurement) 38.7 ± 0.9
BMI 28.8 ± 2.6
Mothers
n = 162
Newborns
n = 76
Severe deficiency (≤ 10 ng/mL) (n,%) 57, 35.1 40, 52.6
Mild deficiency (10–20 ng/mL) (n,%) 57, 35.1 26, 34.2
Normal level (≥ 20 ng/mL) (n,%) 48, 29.8 10, 13.1
Average level ± SD (ng/mL ) 15.06 ± 6.9 12.32 ± 4.8
SD — standard deviation, BMI — body mass index
Thymus perimeter differed significantly with regard 
to the level of both, maternal and fetal VDD (≤ 10, 10–20 
and ≥ 20 ng/mL) (p = 0.04, p = 0.03) (Table 2).
Table 2. The relationship thymus perimeter with 25(OH)D3 concentrations in both maternal serum at mid-pregnancy and umbilical cord serum 
at delivery
Thymus perimeter p Thymus perimeter p
Severe deficiency, umbilical cord
(≤ 10 ng/mL, n = 40) 76.9
b
0.03
Severe deficiency, maternal serum
(≤ 10 ng/mL, n = 29) 78.3
a
0.04Mild deficiency umbilical cord(10–20 ng/mL, n = 26) 83.7
b Mild deficiency maternal serum
(10–20 ng/mL, n = 26) 85.1
b
Normal level, umbilical cord
(≥ 20 ng/mL, n = 10) 94
a Normal level, maternal serum 
(≥ 20 ng/mL, n = 19) 92.9
c
p < 0.05 statistical significance
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DISCUSSION
In this prospective study, we investigated the correla-
tion between both, mid-pregnancy maternal and neonatal 
vitamin D levels and fetal thymus size. We found a statisti-
cally significant correlation between vitamin D level and 
thymus perimeter (r = 0.45, p = 0.04 and r = 0.43, p < 0.01, 
respectively). Moreover, both maternal and neonatal VDD 
levels were associated with decreased thymus perimeter 
(p = 0.04, p = 0.03). To the best of our knowledge, this has 
been the first study to evaluate the effect of VDD on thy-
mus size in humans. The relationship between vitamin D 
and thymus has been investigated in two animal studies 
and their results are conflicting. Harvey et al., revealed that 
pregnant rats with VDD exhibit increased growth of cen-
tral but not peripheral immune organs of the fetal thymus 
and leukocytes obtained from these fetuses demonstrated 
a pro-inflammatory phenotype [19]. These researches sug-
gested that vitamin D may suppress growth hormone at 
the cellular level and an increase in fetal thymus weight 
might be associated with increased expression of insulin-like 
growth factor II (IGF-II). In a study conducted by Yurdakök et 
al., rats with VDD were not different from healthy controls 
in terms of thymus weight and histology [20]. 
Growing evidence shows increased inflammatory pro-
cesses in patients with low vitamin D status, but little is 
known about this relationship during pregnancy [21, 22]. 
A recent study revealed that early pregnancy vitamin D 
status is associated with some inflammatory biomarkers in 
mid-pregnancy [23]. In a recent animal study, researchers 
showed that maternal VDD leads to aberrant inflammatory 
responses in the fetus [24]. Preeclampsia is the most extreme 
point of systemic inflammatory response and offers a good 
opportunity to assess the inflammatory process in preg-
nancy. Two recent studies have demonstrated that second 
trimester thymus size in preeclamptic pregnant women is 
smaller than in healthy controls [18, 25]. The researchers 
claimed that preeclampsia triggers an acute-phase reaction 
in the fetus, leading to activation of the hypothalamo-pitu-
itary-adrenal (HPA) axis and cortisol release. Endogenous 
cortisol subsequently binds to its receptor in cortical thymo-
cytes and induces apoptosis and thymic involution. Interest-
ingly, some resent studies found that maternal vitamin D 
deficiency was associated with severe preeclampsia [26, 27]. 
Similarly, decreased thymus size is observed more frequently 
in cases of chorioamnionitis and thymus size is more sensi-
tive than CRP in predicting histological chorioamnionitis 
[28]. Unlike in animal studies, we found a thymic involution 
in pregnant women with vitamin D deficiency. The inflam-
matory process which occurs as a result of VDD may have 
led to a reduction in the thymus size. 
Recent studies have revealed that maternal and fetal VDD 
is common throughout the world [29, 30]. In our study, we 
observed normal 25(OH)D3 serum concentrations in 48 moth-
ers (29.8%) and 10 neonates (12.1%). Fetal vitamin D is sup-
plied by the mother and umbilical cord vitamin D levels are 
correlated with maternal vitamin D levels [31]. Similarly, we 
observed a positive correlation between cord blood and 
mid-pregnancy maternal vitamin D levels (r = 0.8, p < 0.01). 
The high prevalence of vitamin D deficiency during preg-
nancy increases the importance of studies investigating the 
effect of vitamin D on fetal programming. Recent studies have 
implicated that vitamin D may have an important, multifac-
eted role in the development of fetal lungs, brain, and bone 
[5, 8, 32]. Similarly, the results of our study suggested that VDD 
during pregnancy can affect fetal programming of thymus.
Ultrasound image quality has dramatically increased, 
and assessment of thymus size has become feasible in most 
human pregnancies. In a study comparing ultrasonography 
with magnetic resonance (MR), ultrasonographic evaluation 
was found to have similar sensitivity to MR [33]. Ultrasonic 
measurements of fetal diameter are closely correlated with 
measurements of thymic volume obtained during autopsy 
[34]. The fetal thymus was imaged in transverse at the point 
of the upper mediastinum adjacent to the three large cardiac 
vessels. This image is relatively easy to obtain during the 
second trimester [18, 25]. Obtaining a suitable transverse 
image is difficult in the third trimester. That is why the image 
quality did not meet our expectations in 44 of 162 pregnant 
women included in our study. In a study conducted by 
De Leon-Luis et al., concordance of 95% was observed for 
thymus circumference and thymus/thorax diameter. That 
measurement was not influenced by fetal sex [35]. Our study 
also revealed a positive correlation between thymus circum-
ference and thymus/thorax diameter (r = 0.44, p < 0.01). 
Therefore, we used the thymus diameter as the thymus size 
for subsequent statistical analysis.
Several important limitations apply to our study. First, 
the study group included a small sample of pregnant wom-
en and studies with a larger and more diverse study popu-
lations are necessary. Secondly, while we included mature 
neonates and we examined fetal thymic-thoracic ratio in 
our study, we did not investigate the association between 
fetal weight and fetal thymus measurements. Finally, the 
effect of different doses of vitamin D on thymic size was not 
evaluated. For future studies, we suggest that randomized 
controlled trials measure fetal thymic size during the second 
trimester in mothers receiving vitamin D replacement.
In conclusion, fetal VDD is a common occurrence world-
wide. VDD during pregnancy can affect fetal programming 
of the thymus. Furthermore, these data suggest that vitamin 
D deficiency during pregnancy may lead to systemic inflam-
matory response in the fetus. Thus, more research attention 
and patient awareness of the role of vitamin D in immune 
development is necessary.
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